Abstract
Introduction: Cell therapy for myocardial angiogenesis or regeneration is currently subject of clinical pilot trials. Suitable inclusion criteria, however, remain to be defined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have